Trial Information

Summary: Trial to Assess the Long-Term Safety of Oral Lacosamide in Patients With Partial-Onset Seizures

A Multicenter, Open-Label Extension Trial to Assess the Long-Term Safety and Tolerabiity of Lacosamide as Adjunctive Therapy in Subjects With Partial-Onset Seizures

Inclusion Criteria:

• Eligible subjects who participated in SP925 for treatment of partial-onset seizures

Exclusion Criteria:

• Receiving any study drug or experimental device other than lacosamide. Meets withdrawal criteria for parent trial or experiencing ongoing serious adverse event.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: June 1, 2008 at 6:44:34 AM